Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -5.26% is 64% below its 5-year average of -3.22%, around the middle of its 5-year range (-15.06%–2.97%).
2868.42% below its 12-month average of 0.19%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.09%.
RETURN ON ASSETS (ROA)
-5.26%
RETURN ON ASSETS (ROA) AVG TTM
0.19%
RETURN ON ASSETS (ROA) AVG 3Y
-3.34%
RETURN ON ASSETS (ROA) AVG 5Y
-3.22%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-2868.42%
CURRENT VS 3Y AVG
-57.60%
CURRENT VS 5Y AVG
-63.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.17%
median of 451 covered companies
CURRENT VS SECTOR MEDIAN
+79.10%
vs the sector median at left
AdaptHealth Corp.
Market Cap
$780.95M
Return on Assets (ROA)
-5.26%
TTM Avg
0.19%
3Y Avg
-3.34%
5Y Avg
-3.22%
Market Cap
$776.24M
Return on Assets (ROA)
-13.47%
TTM Avg
-22.22%
3Y Avg
-41.40%
5Y Avg
-40.82%
Market Cap
$775.72M
Return on Assets (ROA)
-32.91%
TTM Avg
-25.26%
3Y Avg
-23.04%
5Y Avg
-20.66%
Market Cap
$786.48M
Return on Assets (ROA)
-18.03%
TTM Avg
-7.81%
3Y Avg
-4.40%
5Y Avg
-1.35%
Market Cap
$774.32M
Return on Assets (ROA)
-36.55%
TTM Avg
-44.22%
3Y Avg
-44.22%
5Y Avg
-44.22%
Market Cap
$767.46M
Return on Assets (ROA)
-20.44%
TTM Avg
-45.26%
3Y Avg
-91.41%
5Y Avg
-102.66%
Market Cap
$812.20M
Return on Assets (ROA)
10.76%
TTM Avg
17.66%
3Y Avg
20.82%
5Y Avg
23.86%
Market Cap
$749.55M
Return on Assets (ROA)
-42.53%
TTM Avg
-41.06%
3Y Avg
-49.54%
5Y Avg
-47.47%
Market Cap
$819.44M
Return on Assets (ROA)
-8.70%
TTM Avg
6.33%
3Y Avg
-16.09%
5Y Avg
-46.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $780.95M | -5.26% | 0.19% | -3.34% | -3.22% |
| Geron Corporation (GERN)vs › | $776.24M | -13.47% | -22.22% | -41.40% | -40.82% |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | -32.91% | -25.26% | -23.04% | -20.66% |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | -18.03% | -7.81% | -4.40% | -1.35% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | -36.55% | -44.22% | -44.22% | -44.22% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | -20.44% | -45.26% | -91.41% | -102.66% |
| InMode Ltd. (INMD)vs › | $812.20M | 10.76% | 17.66% | 20.82% | 23.86% |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | -42.53% | -41.06% | -49.54% | -47.47% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | -8.70% | 6.33% | -16.09% | -46.82% |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | -38.01% | -251.96% | -211.47% | -174.45% |
ROA
-5.3%
ROE
-16.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -1.64% |
| 2024-12-31 | 2.02% |
| 2023-12-31 | -15.06% |
| 2022-12-31 | 1.33% |
| 2021-12-31 | 2.97% |
| 2020-12-31 | -8.91% |
| 2019-12-31 | -3.90% |
| 2018-12-31 | 0.82% |
| 2017-12-31 | -0.22% |
| 2016-12-31 | 0.00% |
